Overview
Tsz-wing Leung practices practicing medicine in Hong Kong, Hong Kong Special Administrative Region.
Leung is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Astigmatism, Nearsightedness, and Triple-Negative Breast Cancer.
They are actively involved in clinical research, co-authoring 23 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tsz-wing S. Leung
Is Tsz-wing S. Leung a top-rated expert for Astigmatism?
MediFind is an objective health platform that identifies experts based on real-world data. Tsz-wing S. Leung is classified as an Advanced expert for Astigmatism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tsz-wing S. Leung participate in research or clinical trials?
Yes. Tsz-wing S. Leung has published 23 articles and abstracts on conditions like Astigmatism. You can view a list of Tsz-wing S. Leung's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AstigmatismLeung isAdvanced. Learn about Astigmatism.
- Experienced
- NearsightednessLeung isExperienced. Learn about Nearsightedness.
- Triple-Negative Breast CancerLeung isExperienced. Learn about Triple-Negative Breast Cancer.